Skip to main content
SpringerLink
Log in

Contraception and Cardiovascular Disease

  • Chapter
  • First Online:
Book cover Pregnancy and Congenital Heart Disease

Part of the book series: Congenital Heart Disease in Adolescents and Adults ((CHDAA))

  • 953 Accesses

Abstract

Early contraceptive advice is essential in women with heart disease and should be considered as an integral part of standard treatment in these women. When considering a contraceptive method, the efficacy, inherent risks and benefits are evaluated in relation to the particularities of the cardiac condition. For this, potential interactions with cardiovascular drugs, effects on coagulation and haemodynamics are of particular importance. By appropriate counselling, including the woman’s preference, personalised advice is given by a multidisciplinary team. In this chapter, we consider the different methods of contraception in relation to the type of heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

COC:

Combined oral contraceptives

DMPA:

Depot-medroxyprogesterone acetate

IUDs:

Intrauterine devices

LARC:

Long-acting reversible contraceptives

LNG-IUS:

Levonorgestrel-releasing intrauterine system

PCOS:

Polycystic ovary syndrome

PID:

Pelvic inflammatory disease

WHO-MEC:

WHO medical eligibility criteria

References

  1. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31(23):2915–2957

    Article  PubMed  Google Scholar 

  2. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K et al (2013) Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 34(9):657–665

    Article  PubMed  Google Scholar 

  3. Kaunitz AM (1999) Oral contraceptive health benefits: perception versus reality. Contraception 59(1 Suppl):29s–33s

    Article  CAS  PubMed  Google Scholar 

  4. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95(2):261–266

    CAS  PubMed  Google Scholar 

  5. Dragoman MV (2014) The combined oral contraceptive pill – recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol 28(6):825–834

    Article  PubMed  Google Scholar 

  6. Wellings K, Brima N, Sadler K, Copas AJ, McDaid L, Mercer CH et al (2015) Stopping and switching contraceptive methods: findings from Contessa, a prospective longitudinal study of women of reproductive age in England. Contraception 91(1):57–66

    Article  PubMed  Google Scholar 

  7. Rogers P, Mansour D, Mattinson A, O’Sullivan JJ (2007) A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care R Coll Obstet Gynaecol 33(1):17–21

    Article  Google Scholar 

  8. Pijuan-Domenech A, Baro-Marine F, Rojas-Torrijos M, Dos-Subira L, Pedrosa-Del Moral V, Subirana-Domenech MT et al (2013) Usefulness of progesterone-only components for contraception in patients with congenital heart disease. Am J Cardiol 112(4):590–593

    Article  CAS  PubMed  Google Scholar 

  9. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N et al (2006) Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care, R Coll Obstet Gynaecol 32(2):75–81

    Article  Google Scholar 

  10. Trussell J (2011) Contraceptive failure in the United States. Contraception 83(5):397–404

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mansour D, Bahamondes L, Critchley H, Darney P, Fraser IS (2011) The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users. Contraception 83(3):202–210

    Article  CAS  PubMed  Google Scholar 

  12. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS (2008) The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care Off J Eur Soc Contracept 13(Suppl 1):13–28

    Article  CAS  Google Scholar 

  13. Modesto W, Bahamondes MV, Bahamondes L (2014) A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod 29(7):1393–1399

    Article  CAS  PubMed  Google Scholar 

  14. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197

    Article  PubMed  Google Scholar 

  15. WHO Guidelines Approved by the Guidelines Review Committee. Medical eligibility criteria for contraceptive use (2015) World Health Organization, Geneva. Copyright (c) World Health Organization 2015

    Google Scholar 

  16. Mohan AR, Nelson-Piercy C (2014) Drugs and therapeutics, including contraception, for women with heart disease. Best Pract Res Clin Obstet Gynaecol 28(4):471–482

    Article  PubMed  Google Scholar 

  17. Milsom I, Korver T (2008) Ovulation incidence with oral contraceptives: a literature review. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care R Coll Obstet Gynaecol 34(4):237–246

    Article  Google Scholar 

  18. Anderson FD (2006) Safety and efficacy of an extended-regimen oral contraception utilizing low-dose ethinyl estradiol. Contraception 74(4):355

    Article  PubMed  Google Scholar 

  19. Dong W, Colhoun HM, Poulter NR (1997) Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994. J Hypertens 15(10):1063–1068

    Article  CAS  PubMed  Google Scholar 

  20. Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366(24):2257–2266

    Article  CAS  PubMed  Google Scholar 

  21. Silversides CK, Sermer M, Siu SC (2009) Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 11(4):298–305

    Article  PubMed  Google Scholar 

  22. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429

    Article  PubMed  Google Scholar 

  23. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747

    Article  PubMed  Google Scholar 

  24. Ellison J, Thomson AJ, Greer IA, Walker ID (2000) Drug points: apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ (Clin Res Ed) 321(7273):1382

    Article  CAS  Google Scholar 

  25. Thorne S, MacGregor A, Nelson-Piercy C (2006) Risks of contraception and pregnancy in heart disease. Heart 92(10):1520–1525

    Article  PubMed  PubMed Central  Google Scholar 

  26. Korver T, Klipping C, Heger-Mahn D, Duijkers I, van Osta G, Dieben T (2005) Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake. Contraception 71(1):8–13

    Article  CAS  PubMed  Google Scholar 

  27. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI (2012) Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ (Clin Res Ed) 345:e4944

    CAS  Google Scholar 

  28. Wald RM, Sermer M, Colman JM (2011) Pregnancy and contraception in young women with congenital heart disease: general considerations. Paediatr Child Health 16(4):e25–e29

    PubMed  PubMed Central  Google Scholar 

  29. Espey E, Ogburn T (2011) Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol 117(3):705–719

    Article  PubMed  Google Scholar 

  30. Stephen Searle E (2014) The intrauterine device and the intrauterine system. Best Pract Res Clin Obstet Gynaecol 28(6):807–824

    Article  CAS  PubMed  Google Scholar 

  31. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I (2011) Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 84(5):e11–e16

    Article  CAS  PubMed  Google Scholar 

  32. Kapp N, Curtis KM (2009) Intrauterine device insertion during the postpartum period: a systematic review. Contraception 80(4):327–336

    Article  PubMed  Google Scholar 

  33. Vigl M, Kaemmerer M, Niggemeyer E, Nagdyman N, Seifert-Klauss V, Trigas V et al (2010) Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol 105(4):538–541

    Article  PubMed  Google Scholar 

  34. Huq FY, Tvarkova K, Arafa A, Kadir RA (2011) Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation. Contraception 84(2):128–132

    Article  CAS  PubMed  Google Scholar 

  35. Zingone MM, Guirguis AB, Airee A, Cobb D (2009) Probable drug interaction between warfarin and hormonal contraceptives. Ann Pharmacother 43(12):2096–2102

    Article  PubMed  Google Scholar 

  36. Murray S, Hickey JB, Houang E (1987) Significant bacteremia associated with replacement of intrauterine contraceptive device. Am J Obstet Gynecol 156(3):698–700

    Article  CAS  PubMed  Google Scholar 

  37. Everett ED, Reller LB, Droegemueller W, Greer BE (1976) Absence of bacteremia after insertion or removal of intrauterine devices. Obstet Gynecol 47(2):207–209

    CAS  PubMed  Google Scholar 

  38. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT et al (2008) ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52(8):676–685

    Article  PubMed  Google Scholar 

  39. Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (2008) National Institute for Health and Clinical Excellence (UK) National Institute for Health and Clinical Excellence, London

    Google Scholar 

  40. Grimes DA, Schulz KF (2001) Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev (2):Cd001327

    Google Scholar 

  41. Ladipo OA, Farr G, Otolorin E, Konje JC, Sturgen K, Cox P et al (1991) Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion. Adv Contracept Off J Soc Adv Contracept 7(1):43–54

    Article  CAS  Google Scholar 

  42. Sinei SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM et al (1990) Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 97(5):412–419

    Article  CAS  PubMed  Google Scholar 

  43. Walsh TL, Bernstein GS, Grimes DA, Frezieres R, Bernstein L, Coulson AH (1994) Effect of prophylactic antibiotics on morbidity associated with IUD insertion: results of a pilot randomized controlled trial, IUD Study Group. Contraception 50(4):319–327

    Article  CAS  PubMed  Google Scholar 

  44. Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH (2015) Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet (Lond, Engl) 385(9974):1219–1228

    Article  Google Scholar 

  45. Suri V, Aggarwal N, Kaur R, Chaudhary N, Ray P, Grover A (2008) Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease. Contraception 78(4):315–318

    Article  CAS  PubMed  Google Scholar 

  46. Gemzell-Danielsson K, Mansour D, Fiala C, Kaunitz AM, Bahamondes L (2013) Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 19(4):419–427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ott J, Promberger R, Kaufmann U, Huber JC, Frigo P (2009) Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation. Arch Gynecol Obstet 280(5):811–814

    Article  PubMed  Google Scholar 

  48. Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG, Veldtman GR, Johnson MR (2015) Contraception and cardiovascular disease. Eur Heart J 36(27):1728–1734, 34a-34b

    Article  PubMed  Google Scholar 

  49. Jacobstein R, Polis CB (2014) Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynaecol 28(6):795–806

    Article  PubMed  Google Scholar 

  50. Aznar R, Reynoso L, Ley E, Gamez R, De Leon MD (1976) Electrocardiographic changes induced by insertion of an intrauterine device and other uterine manipulations. Fertil Steril 27(1):92–96

    Article  CAS  PubMed  Google Scholar 

  51. Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–9. BMJ (Clin Res Ed) 343:d6423

    Article  Google Scholar 

  52. Culwell KR, Curtis KM (2009) Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. Contraception 80(4):337–345

    Article  CAS  PubMed  Google Scholar 

  53. Kadir RA, Chi C (2007) Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy. Contraception 75(6 Suppl):S123–S129

    Article  CAS  PubMed  Google Scholar 

  54. Pisoni CN, Cuadrado MJ, Khamashta MA, Hunt BJ (2006) Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus 15(12):877–880

    Article  CAS  PubMed  Google Scholar 

  55. Sordal T, Inki P, Draeby J, O’Flynn M, Schmelter T (2013) Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial. Obstet Gynecol 121(5):934–941

    Article  CAS  PubMed  Google Scholar 

  56. Lidegaard O, Nielsen LH, Skovlund CW, Lokkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–10. BMJ (Clin Res Ed) 344:e2990

    Google Scholar 

  57. Goldstein J, Cushman M, Badger GJ, Johnson JV (2007) Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 87(6):1267–1270

    Article  CAS  PubMed  Google Scholar 

  58. Snabes MC, Poindexter AN 3rd (1991) Laparoscopic tubal sterilization under local anesthesia in women with cyanotic heart disease. Obstet Gynecol 78(3 Pt 1):437–440

    CAS  PubMed  Google Scholar 

  59. Hillis SD, Marchbanks PA, Tylor LR, Peterson HB (1999) Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 93(6):889–895

    CAS  PubMed  Google Scholar 

  60. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J (1996) The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 174(4):1161–1168; discussion 8–70

    Article  CAS  PubMed  Google Scholar 

  61. Adelman MR, Dassel MW, Sharp HT (2014) Management of complications encountered with Essure hysteroscopic sterilization: a systematic review. J Minim Invasive Gynecol 21(5):733–743

    Article  PubMed  Google Scholar 

  62. Famuyide AO, Hopkins MR, El-Nashar SA, Creedon DJ, Vasdev GM, Driscoll DJ et al (2008) Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc 83(4):431–438

    Article  PubMed  Google Scholar 

  63. Duffy S, Marsh F, Rogerson L, Hudson H, Cooper K, Jack S et al (2005) Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 112(11):1522–1528

    Article  PubMed  Google Scholar 

  64. Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D et al (2003) Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study. Hum Reprod 18(6):1223–1230

    Article  PubMed  Google Scholar 

  65. Dhruva SS, Ross JS, Gariepy AM (2015) Revisiting essure – toward safe and effective sterilization. N Engl J Med 373(15), e17

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Franciscus Gasthuis, Rotterdam, The Netherlands

    Jan S. Erkamp MD

  2. Department of Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands

    Jérôme Cornette MD, PhD

Authors
  1. Jan S. Erkamp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérôme Cornette MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jérôme Cornette MD, PhD .

Editor information

Editors and Affiliations

  1. Erasmus MC University Medical Center, Rotterdam, Gelderland, The Netherlands

    Jolien W. Roos-Hesselink

  2. Chelsea and Westminster Hospital, London, United Kingdom

    Mark R. Johnson

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Erkamp, J.S., Cornette, J. (2017). Contraception and Cardiovascular Disease. In: Roos-Hesselink, J., Johnson, M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-38913-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-38911-0

  • Online ISBN: 978-3-319-38913-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation